Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Title Intervention NCT IDsort descending Sponsor Status
Study of 9cUAB30 in Healthy Participants Laboratory Biomarker Analysis, Pharmacological Study, Retinoid 9cUAB30 NCT00896974 National Cancer Institute (NCI) Completed
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention NCT00983580 National Cancer Institute (NCI) Active, not recruiting
Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung... medical chart review, computed tomography, computer-aided detection/diagnosis NCT01540552 M.D. Anderson Cancer Center Completed
Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Retinoid 9cUAB30 NCT01935960 National Cancer Institute (NCI) Completed
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers linaclotide acetate, placebo, pharmacological study, laboratory biomarker analysis NCT01950403 Mayo Clinic Completed
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch... Laboratory Biomarker Analysis, Naproxen, Placebo NCT02052908 National Cancer Institute (NCI) Active, not recruiting
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Pomegranate-Extract Pill NCT02095145 National Cancer Institute (NCI) Active, not recruiting
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current... Aspirin, Laboratory Biomarker Analysis, Placebo NCT02123849 National Cancer Institute (NCI) Completed
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline NCT02134925 National Cancer Institute (NCI) Active, not recruiting
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Aspirin, Laboratory Biomarker Analysis, Placebo NCT02169271 National Cancer Institute (NCI) Active, not recruiting

Pages